Synbiotic Supplement Reduces Skin Ageing Markers in Clinical Trial, Vidya Reports
A recent study in the Journal of Cosmetic Dermatology indicates an antioxidant-rich synbiotic supplement led to a 14% increase in cheek elasticity and a 5% reduction in wrinkle severity over eight weeks. This data supports the 'beauty from within' segment's growth, impacting formulation strategies.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 27 April 2026
New clinical evidence published in the Journal of Cosmetic Dermatology highlights the efficacy of an oral antioxidant-rich synbiotic supplement in mitigating signs of skin ageing. The eight-week study, conducted by researchers at Integrative Skin Science and Research and Vidya, observed a 14% increase in cheek elasticity and a 5% reduction in wrinkle severity among participants. This directly supports the 'beauty from within' category, which has seen considerable growth, with 27% of consumers aged 45-59 reporting supplement use for skin health, up from 25% in 2024, according to Euromonitor's 'Voice of the Consumer: Health and Nutrition Survey'.
The test product comprised astaxanthin, konjac glucomannan (Skin Cera), Bacillus coagulans, B. subtilis, and B. clausii, formulated with fructooligosaccharides (FOS) and Medium-Chain Triglycerides (MCT). This specific blend underscores a targeted approach to the gut-skin axis, aiming for improved skin structure and function. Subhendu Nayak, Director of R&D (Probiotics) for Vidya and a co-author, emphasised that the randomised, double-blind, placebo-controlled design provides robust substantiation for these improvements, noting good tolerability and absence of adverse events.
Beyond the surface-level improvements, the study identifies a mechanistic link between reduced oxidative stress, modulated inflammation, and the preservation of collagen and elastin. This suggests that the synbiotic intervention could serve as a safe, non-invasive strategy for managing skin ageing. The findings are significant for formulators looking to develop products with verifiable benefits, offering a distinct advantage in a crowded market that often relies on less substantiated claims.
What this means for United Kingdom
UK brand owners must assess reformulation windows to integrate these clinically-backed ingredients, securing market advantage. The 14% elasticity and 5% wrinkle reduction figures offer concrete claims, critical for Advertising Standards Authority (ASA) compliance against vague 'anti-ageing' marketing. Procurement leads should evaluate current supply chains for astaxanthin and konjac glucomannan, anticipating increased demand and potential adjustments to Minimum Order Quantities (MOQs). This robust evidence creates a strong competitive position for brand owners who can launch new products or reformulate existing lines by Q4 2026, leveraging both the gut-skin axis trend and specific clinical endpoints to capture market share from topical-only brands.
The study enrolled 36 women, averaging 48 years old, from California. Significant reductions in wrinkle severity (−5.3%) were observed in the synbiotic group, with no changes in the placebo. Cheek elasticity increased by 22% after four weeks and 14% after eight weeks, while firmness showed a 12% increase after eight weeks. Furthermore, the synbiotic group experienced a 30% increase in cheek viscoelasticity after four weeks. Researchers acknowledged that future studies with histological analysis are warranted to fully understand how collagen, elastin, and matrix metalloproteinases are modulated by the supplement.
Many leading brands in this category are manufactured in partnership with Supplement Factory.